LivaNova PLC (LIVN) earnings date
Feb 24, 2027, before open estimated
Estimated from the company's SEC filing cadence. The company has not confirmed it. Companies usually announce two to four weeks ahead.
- Fiscal period
- Q4 FY2026
- Confidence
- 52% chance of landing within a day
- Source
- Filing history on EDGAR
- Last checked
- 2026-11-19
Read by software from public filings and company announcements. Can be wrong. Verify with the company or the SEC. Not investment advice.
How this company behaves
| Announces its report date | Not enough announcements on file yet to say |
| Reports after the quarter ends | 36 days, typically, give or take 9 (last 8 releases) |
Last 8 releases
| Period | Released | Timing | Days after period end | Filing |
|---|---|---|---|---|
| Q3 FY2026 | Wed, Nov 4, 2026 | before open | 35 | 8-K |
| Q2 FY2026 | Wed, Aug 5, 2026 | before open | 36 | 8-K |
| Q1 FY2026 | Wed, May 6, 2026 | before open | 36 | 8-K |
| Q4 FY2025 | Wed, Feb 25, 2026 | before open | 56 | 8-K |
| Q3 FY2025 | Wed, Nov 5, 2025 | before open | 36 | 8-K |
| Q2 FY2025 | Wed, Aug 6, 2025 | before open | 37 | 8-K |
| Q1 FY2025 | Wed, May 7, 2025 | before open | 37 | 8-K |
| Q4 FY2024 | Tue, Feb 25, 2025 | before open | 56 | 8-K |
What they guided beta
| Q3 FY2026 | "Document EXHIBIT 99.1 NEWS RELEASE LivaNova Reports Third-Quarter 2026 Results; Raises Full-Year 2026 Revenue and Adjusted Diluted EPS Guidance – Delivered 9.9% reported and 10.0% constant-currency revenue growth – Raised full-year 2026 revenue and adjusted diluted earnings per share guidance (1) – Achieved a key milestone in scaling oxygenator production capacity with the operational launch of a dedicated manufacturing line GLOUCESTER, United Kingdom, November 4, 2026 — LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today reported results for the third quarter ende" exhibit |
| Q3 FY2026 | "Raised full-year 2026 revenue growth range by 100 basis points to 9% to 10% on a constant-currency basis." exhibit |
| Q3 FY2026 | "Raised full-year 2026 adjusted diluted earnings per share range by $0.10 at midpoint to $4.40 to $4.50." exhibit |
| Q3 FY2026 | "In October 2026, the American Medical Association CPT® Editorial Panel announced the establishment of new Category I Current Procedural Terminology (CPT®) codes that include LivaNova’s proximal hypoglossal nerve stimulation therapy for the treatment of moderate to severe obstructive sleep apnea, with an expected effective date of January 1, 2028" exhibit |
| Q3 FY2026 | "Our updated 2026 guidance reflects confidence across the portfolio as we advance our strategic priorities, drive innovation to address important unmet patient needs, and remain focused on delivering long-term shareholder value.”" exhibit |
| Q2 FY2026 | "Document EXHIBIT 99.1 NEWS RELEASE LivaNova Reports Second-Quarter 2026 Results; Raises Full-Year 2026 Revenue and Adjusted Diluted EPS Guidance – Delivered double-digit reported revenue growth of 10.8%, with constant-currency revenue growth of 9.8% – Raised full-year 2026 revenue and adjusted diluted earnings per share guidance (1) – Entered into a long-term agreement with Thermo Fisher Scientific to strengthen oxygenator component supply to expand manufacturing output and satisfy unmet demand GLOUCESTER, United Kingdom, August 5, 2026 — LivaNova PLC (Nasdaq: LIVN), a market-leading medical" exhibit |
| Q2 FY2026 | "Raised full-year 2026 revenue growth range by 100 basis points to 8% to 9% on a constant-currency basis." exhibit |
| Q2 FY2026 | "Raised full-year 2026 adjusted diluted earnings per share range by $0.10 at midpoint to $4.30 to $4.40." exhibit |
| Q2 FY2026 | "Lowered full-year 2026 adjusted free cash flow range to $140 million to $160 million" exhibit |
| Q2 FY2026 | "Our updated 2026 guidance reflects strong execution in the core businesses as we advance our strategic plan and drive long-term value creation.”" exhibit |
Get this as JSON
curl -H "X-API-Key: vt_live_..." https://api.veritasdata.dev/v1/next/LIVN
# how far back the record goes for this company
curl -H "X-API-Key: vt_live_..." https://api.veritasdata.dev/v1/coverage/LIVN
Put this date on your page
A badge that stays current. It links back to this page and needs no key. Embed it unmodified, with its link to this page intact: the badge is too small to carry the notice below, so the page it links to does.
Read by software from public filings and company announcements. Can be wrong. Verify with the company or the SEC. Not investment advice.
HTML
<a href="https://veritasdata.dev/company/LIVN/"><img src="https://veritasdata.dev/embed/LIVN.svg" alt="LIVN earnings date" width="240" height="56"></a>
Markdown
[](https://veritasdata.dev/company/LIVN/)
Script
<script async src="https://veritasdata.dev/embed/LIVN.js"></script>
Get a free key: 100 calls, every company
Sign in with GitHub or Google. The key works on every endpoint and in the MCP server.
curl -H "X-API-Key: vt_live_..." "https://api.veritasdata.dev/v1/next/LIVN"
Dates come only from SEC EDGAR and company announcements. Nothing here is investment advice.